The induction of EMT in immortalized, nontumorigenic human mammary epithelial cells resulted in acquisition of the CD44+/CD24– phenotype, a characteristic of breast cancer stem-like cells (CSC). The gene discussed is CD24; the disease is breast carcinoma.